covid19

Top stories:

• Covid and TB spreading at ICE concentration camps
• Winter Olympic athletes are taking Covid precautions
• “The U.S.’s long winter COVID-19 wave continues”
• US AMA forms new vaccine review group apart from FDA, CDC
• Portugal, Germany and Thailand reimpose Covid testing for China arrivals amid concern over fast-spreading XBB variant
• Director Jeong Jin-woo dies at 88 after fall and Covid complications
• Long Covid could trigger symptoms similar to Alzheimer’s, new study says
• A guide to Covid toe and Covid skin problems we wish we didn't need
• Two great upcoming Long Covid events (online)
• Covid denial king Vinay Prasad personally prevents Americans from getting Moderna's new flu vaccine

Last year's Novavax COVID-19 vaccine finder from the company itself is gone, there's nothing in the press about Novavax availability beyond saying it will be available "in the fall," and since reddit locked their cesspool down, searching "novavax reddit" with time range of "last month" is useless.

Thus I am starting a thread for anyone seeking the Novavax shot to share info. Please post if you find it, and if comfortable sharing, where.

UPDATE: Nuvaxovid locator is now online!

https://www.nuvaxovid.com/vaccine-locator

crossposted from: https://feddit.org/post/18296646

Original article in German: 3.000 Long-COVID Betroffene informieren sich über neue Nikotinpflastertherapie

Via this Mastodon post (in German).

COVID-19 infection was linked to a higher risk of new-onset mild and moderate chronic kidney disease (CKD) in US children and adolescents from 2020 to 2023, according to recent findings from the National Institutes of Health's Researching COVID to Enhance Recovery (RECOVER) initiative.

The University of Pennsylvania-led research team assessed data on kidney outcomes from 1.9 million patients aged 20 years and younger with (487,400) and without (1.4 million) COVID-19 at 19 healthcare centers from March 2020 to May 2023, with up to 2 years of follow-up. The average age was 8.2 years, 51.0% were male, and 45% were White.

The results were published late last week in JAMA Network Open.

A clinical survey of 85 pediatric long-COVID patients in Bavaria, Germany, reveals high levels of fatigue, loss of motivation, difficulty concentrating and maintaining attention, worsened mood, and greater anxiety. A

To holistically describe long-COVID symptoms and identify risk factors for post-infection neurocognitive and emotional problems, University of Regensburg researchers analyzed clinical data from COVID-19 survivors aged 12 to 17 years who had symptoms for at least 4 weeks. The average patient age was 12.5 years, 61.2% were girls, and the average interval from infection to examination was 5.7 months.

From December 2021 to June 2023, the children were given a neuropsychological evaluation made up of infection-specific interviews, psychopathologic exams, questionnaires on emotional well-being and behavioral problems, and computerized tests measuring concentration, attention, and memory. Participants also underwent neurologic, pneumological, gastrointestinal, and cardiac testing.

84% had abnormal psychological results. Most children had elevated levels of fatigue (82.4%), loss of motivation (72.9%), impaired concentration and attention (71.8%), and worsened mood (53%), and 31.8% reported more anxiety. The most common diagnoses were post-COVID adjustment disorder (38.8%) and post-COVID attention-deficit disorder (23.5%). Disturbances in attention and memory, drive and psychomotor activity, affect, circadian disturbances, and worries and compulsions were common.

COVID-19 vaccination slashed the risk of experiencing prolonged symptoms by about 27% in fully vaccinated adults who were later infected, estimates a European Centre for Disease Prevention and Control (ECDC) systematic review of 12 studies.

The researchers identified 11 studies on whether COVID-19 vaccination lowers the risk of long COVID, or post-COVID condition (PCC) and 1 study designed to determine whether vaccination reduces both the risk and duration of persistent symptoms. Published after October 2021, the studies used the World Health Organization (WHO) definition of long COVID and were conducted in Europe and similar regions.

The WHO defines long COVID as symptoms 3 months after SARS-CoV-2 infection that last for at least 2 months.

No conclusions about kids, immune-compromised adults. Six studies of adults overall found that full vaccination before infection significantly reduced the odds of developing long COVID compared with no vaccination.

"These studies represented a range of recruitment settings (including both community and hospital settings), time period of infection (and consequently SARS-CoV-2 variant), as well as acute COVID-19 disease severity," the study authors wrote. "In addition, two of the three studies which did not find that vaccination reduced PCC had small sample sizes, particularly where symptoms were assessed in sub-group analyses."

I know hosting video on a decentralized platform takes hella storage and bandwidth, but I think it would be cool to have a new Vine with videos limited to 7 seconds.

However, because the vast majority of COVID-19 cases do not require hospitalization, many more cases of long COVID have arisen from these milder cases despite their lower risk.